The purpose of this study was to evaluate the independent predictive factors for local tumor progression (LTP) of colorectal liver metastasis (CRLM) after radiofrequency ablation (RFA).
INTRODUCTION
Surgical resection is the only curative treatment in patients with colorectal liver metastasis (CRLM) (1) (2) (3) (4) . Unfortunately, only a minority of patients are amenable to surgery, and radiofrequency ablation (RFA) can be an effective alternative therapy for inoperable patients (1, 3, (5) (6) (7) (8) . However, compared to surgical resection, local tumor progression (LTP) of CRLM is usually more common after RFA, although excellent local tumor control has occasionally been reported for small metastatic nodules ≤ 3 cm in the literatures (1, 9-13).
The LTP rates for CRLM after RFA can differ according to the approach, and LTP tends to be more common after percutaneous approaches than after intraoperative approaches (1, 11, 14) .
Owing to the advantages that localization is technically easy even for tumors located in difficult areas and adjacent abdominal organs can be widely separated from the liver (15) , acceptably low LTP rates may be expected for small metastatic nodules ≤ 3 cm after intraoperative RFA (16) . On the other hand, the ablation size usually differs significantly according to the type of electrode, potentially leading to a difference in the LTP rates.
The purpose of this study was to evaluate the independent predictive factors for LTP of CRLM after RFA. 
Analysis of Factors Affecting Local Tumor Progression of Colorectal Cancer Liver Metastasis after Radiofrequency Ablation

MATERIALS AND METHODS
Patient Selection
This is a retrospective study of patients in whom RFA was per- procedures at the start of this study.
The ablation procedure was terminated when the size of the ablation zone on US monitoring was large enough to measure at least 5 mm (18) . Vital signs were monitored during the entire procedure. 
Evaluation of Therapeutic Efficacy and Complications
RESULTS
Patient Characteristics
From January 2006 to December 2015, RFA was performed in our center for 50 consecutive patients with 70 CRLM nodules.
Among them, 38 patients with 58 tumors satisfied the inclusion criteria of this study. Among them, one patient was diagnosed histopathologically, and the other patients were diagnosed clinicoradiologically. All patients, except three, were male. Their ages ranged from 52 to 89 years [mean ± standard deviation (SD):
68.9-9.6 years]. The median follow-up period was 24 months (range: 4-61 months).
Tumor size ranged from 0.5 to 3.7 cm (mean ± SD: 1.8-0.9 cm), while the median tumor size was 1.8 cm. Other baseline tumor characteristics per nodule are described in Table 1 .
Local Tumor Progression Rates and the Predictive Factors
During follow-up, LTP occurred in 14 tumors from nine patients (Figs. 1, 2) . Univariate analysis showed that minimal ablative margin of less than 5 mm was the only significant adverse prognostic factor for LTP (p = 0.003). Also, use of the internally cooled clustered electrode was not statistically significant (p = 0.091) ( Table 2 ). Multivariate analysis showed that tumor size > 2 cm and insufficient ablative margin were two independently significant adverse prognostic factors for LTP (p = 0.045 and 0.022, respectively). Also, the percutaneous approach was not statistically significant (p = 0.455) ( Table 3 ). were 33.1%, 37.9%, and 37.9%, respectively. In contrast, the 1-, 2-, and 3-year LTP rates for intraoperative RFA were 6.7%, 14.4%, and 14.4%, respectively. The difference according to the approach was statistically significant (p = 0.033) (Fig. 3) . 
Complications
In none of the patients, the ablation procedure was stopped because of severe pain. Twenty-one patients died during followup. Side effects after the ablation procedures included mild abdominal pain and intermittent fever in eight patients and one patient, respectively, but no major complication occurred.
DISCUSSION
In this study, we attempted to clarify the prognostic factors for LTP of CRLM after RFA. The finding that tumor size > 2 cm was statistically significant was largely in accordance with the results from a previous study which showed that tumor size of less than 3 cm and ablative margins greater than 5 mm were essential for effective local tumor control (18) . More importantly, this study suggests that a 5 mm ablative margin may suffice for RFA of CRLM, in particular for tumors 2 cm or smaller. Further large scale studies are necessary to evaluate the minimal required ablative margins according to the tumor diameter of CRLM.
In general, the reported LTP rates after open surgical RFA for small nodules ≤ 3 cm were known to be lower than the LTP rates after percutaneous or laparoscopic RFA, which are usually less than 10% (13, 22) . This can be explained by the more versatile directions and clear visualization of tumor margin in operative RFA (13) . These LTP rates for small CRLM less than 3 cm after open surgical RFA were reported to be similar to those obtained by more invasive treatment such as conventional liver surgery (13) . There is still ongoing controversy on whether open surgical RFA may replace surgical resection for these small CRLM nodules (15) .
In this study, we could not compare the LTP rates between the open surgical and laparoscopic approaches because of the small number of patients. The 3-year LTP rate for 20 tumors treated with an intraoperative approach was 14.4%, which was comparable to the results reported in the literature. Notably, this reasonably low LTP rate may be explained by the fact that a sufficient ablative margin was obtained in most tumors treated with intraoperative RFA, including both open surgical and laparoscopic approaches (15) . In this study, the 3-year LTP rate for tumors with sufficient ablative margin was only 4.5%.
The limitations of this study are as follows: first, this was a retrospective analysis, and it may be difficult to derive a strong conclusion. However, the independently significant adverse prognostic factors for LTP largely coincided with those reported in the literature (22) . Second, not all tumors were diagnosed histopathologically. Third, all ablation procedures were performed by a single interventional radiologist in a medical center, and this may limit the generalization of the results of this study. Finally, evaluation of the ablative margin based on visual inspection may be less accurate than that performed by using a dedicated 3D software (23).
In conclusion, favorable outcomes in local tumor control can be expected after RFA of CRLM when the tumor size is less than or equal to 2 cm and a sufficient ablative margin is secured. Although the operative approach has a tendency to show a lower LTP rate than the percutaneous approach, the result did not reach statistical significance. Further large-scale prospective controlled studies are required. 
